Does UPADACITINIB Cause Muscular weakness? 286 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 286 reports of Muscular weakness have been filed in association with UPADACITINIB (Rinvoq). This represents 0.4% of all adverse event reports for UPADACITINIB.
286
Reports of Muscular weakness with UPADACITINIB
0.4%
of all UPADACITINIB reports
13
Deaths
110
Hospitalizations
How Dangerous Is Muscular weakness From UPADACITINIB?
Of the 286 reports, 13 (4.5%) resulted in death, 110 (38.5%) required hospitalization, and 10 (3.5%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 286 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which UPADACITINIB Alternatives Have Lower Muscular weakness Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL